<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A registry of haematopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> was established on January 1, 1980 in order to accurately determine the incidence and epidemiological features of these diseases in the department of CÃ´te d'Or (population 478,000) </plain></SENT>
<SENT sid="1" pm="."><plain>Over five years (1980-1984), 704 new cases were recorded </plain></SENT>
<SENT sid="2" pm="."><plain>The crude incidence rates were 32.7 per 100,000 for males and 24.9 per 100,000 for females </plain></SENT>
<SENT sid="3" pm="."><plain>The corresponding age standardized rates were 26.4 and 16.7 </plain></SENT>
<SENT sid="4" pm="."><plain>The sex ratio was 1.6:1 </plain></SENT>
<SENT sid="5" pm="."><plain>In males, <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemias</z:mpath> were the most common haematopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, followed by non Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> and <z:hpo ids='HP_0006775'>multiple myelomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In females, <z:hpo ids='HP_0006775'>multiple myelomas</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> preceded non Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemias</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>For men and women, the risk of haematopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> was higher in urban areas than in rural areas </plain></SENT>
<SENT sid="8" pm="."><plain>Compared to population based registries in other countries, incidence rates are among the highest reported and are particularly high for <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
</text></document>